Marché mondial du syndrome de Patau – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse du marché et de la taille du syndrome de Patau

Le syndrome de Patau est l'une des maladies les moins fréquentes et les plus graves des trisomies autosomiques viables. La survie médiane des patients est inférieure à 3 jours. Le syndrome de Patau touche environ 1 naissance sur 5 000. De plus, le risque d'avoir un bébé atteint de ce syndrome augmente avec l'âge de la mère. Plus de 9 enfants sur 10 nés avec le syndrome de Patau meurent au cours de la première année. En ce qui concerne son diagnostic, l'analyse cytogénétique est une étape essentielle du diagnostic prénatal du syndrome. On a observé que les patients ont souvent un faible tonus musculaire qui les fait paraître très flexibles, mais ils manquent de force en raison de cette faiblesse combinée à des os fragiles qui entraînent des fractures fréquentes.

Data Bridge Market Research analyse le taux de croissance du marché mondial du syndrome de Patau au cours de la période de prévision 2022-2029. Le TCAC attendu du marché mondial du syndrome de Patau a tendance à être d'environ 25 % au cours de la période de prévision mentionnée. En plus des informations sur le marché telles que la valeur marchande, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe Data Bridge Market Research comprend également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché du syndrome de Patau

Market Definition

Patau syndrome is a rare genetic disorder that occurs when there are extra chromosomes in the cells of the body. This disorder results from the presence of three, instead of the normal two, copies of chromosome 13 (trisomy). This syndrome includes symptoms such as intellectual disabilities or developmental delays, heart defects, neurological disorders such as seizures, or hyperactivity problems that affect behavior or learning ability among others.

Global Patau Syndrome Market Dynamics

Drivers

• Increasing Prevalence of Patau Syndrome

The rising incidence of patau syndrome is boosting the growth of the market. Patau's syndrome affects about 1 in every 5,000 births. With the passing age, the risk of having a baby with the syndrome increases. More than 9 out of 10 children born with patau syndrome die during the first year. Around 1 in 10 babies witnessing less severe forms of the syndrome, such as partial or mosaic trisomy 13, live for more than a year. Thus, it acts as a major driver in the market growth.

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by the rise in the number of research and development activities. This will provide beneficial opportunities for the global patau syndrome market. To encourage researchers and pharmaceutical companies to develop novel medicines, the government is funding research and development (R&D) initiatives.

Opportunities

• Increased Demands of Diagnostic Tests

Different kinds of diagnostic procedures are helping to create opportunities of the global patau Syndrome market. Amniocentesis or chorionic villus sampling (CVS) are available today with regards to this. These are the type of invasive tests to remove a sample of tissue or fluid so that it can be further tested for the presence of the extra copy of chromosome 13. All these factors are contributing in the growth of the market.  

• Increasing Demand of Genetic Testing

The rising demand of genetic testing leads to the market expansion globally. Genetic testing is widely used to help parents plan for future pregnancies. The test results will lead to a more accurate assessment of the likelihood of the syndrome affecting future pregnancies.

Restraints/Challenges

• Lack of Awareness

The sales of potential products are not succeeding much due to the lack of awareness of the syndrome. Though effective treatments are available, but beliefs, poor inadequate communication between clinicians and patients, treatment adherence are the factors impeding the market growth.

• High Cost

The huge expenditure that is associated with the treatment processes hamper the market growth. Numerous market players make huge investment in installing new and advanced treatment procedures to faster the recovery process and in return the cost is increased.

This global patau syndrome market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global patau syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Patau Syndrome Market Scope

The global patau syndrome market is segmented on the basis of treatment, diagnosis, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnosis

• Ultrasounds
• Cell Free DNA Screening
• Pregnancy Associated Plasma Protein A Screening

Treatment

• Surgery
• Therapies

End-User

• Hospitals
• Research Institutes
• Specialty Clinics

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacies
• Others

Global Patau Syndrome Market Regional Analysis/Insights

The global patau syndrome market is analyzed and market size insights and trends are provided by treatment, diagnosis, distribution channel and end-user as referenced above.

The major countries covered in the global patau syndrome market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America is dominating the market in the forecast period due to the presence of key manufacturers of the product is high and, increasing research and development activities, healthcare expenditure contributes in raising the significant growth of the market.

Asia-Pacific is considered to have the most lucrative period due to increased new research and developments on patau syndrome market.

La section par pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte lors de l'analyse prévisionnelle des données nationales.   

Analyse du paysage concurrentiel et des parts de marché mondiales du syndrome de Patau

Le paysage concurrentiel du marché mondial du syndrome de Patau fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liées au marché mondial du syndrome de Patau

Les principaux acteurs opérant sur le marché mondial du syndrome de Patau comprennent :

• Centogene NV (Allemagne)
• Eurofins Découverte (Luxembourg)
• Hoffmann-La Roche SA (Suisse)
• Invitae Corporation (États-Unis)
• LLumina Inc (États-Unis)
• Natera Inc (États-Unis)
• PerkinElmer Inc (États-Unis)
• Quest Diagnostics Incorporated (États-Unis)
• Eurofins LifeCodexx GmbH (Allemagne)
• Ravgen (États-Unis)

SKU-56198